Fed-batch fermentation is the dominant production mode in industrial biotechnology, used for manufacturing products ranging from therapeutic antibodies to industrial enzymes and biofuels. In a fed-batch process, the fermentation begins as a batch culture that consumes the initial media components. Once key nutrients are depleted, concentrated feed solutions are added at controlled rates to sustain growth and production without diluting the culture. This approach avoids substrate inhibition while enabling the accumulation of high cell densities and product titers.
The design of feeding strategies is critical to fed-batch performance. Simple constant-rate feeding can be effective, but more sophisticated approaches using exponential feeding profiles, DO-stat control, or pH-stat strategies often yield superior results. Companies like Ginkgo Bioworks and Culture Biosciences use automated fermentation platforms to systematically screen feeding strategies in parallel, identifying optimal nutrient delivery profiles for each strain and product combination. Advanced process analytical technology (PAT) including Raman spectroscopy and soft sensors enables real-time monitoring of metabolic state, allowing adaptive feeding that responds to the culture's actual needs.
Fed-batch processes typically achieve significantly higher volumetric productivities than simple batch fermentation, but they are limited by the accumulation of inhibitory byproducts and the finite capacity of the reactor vessel. As product and byproduct concentrations rise, cell viability and productivity eventually decline, defining the optimal harvest point. The transition from fed-batch to continuous fermentation can theoretically overcome these limitations, but practical challenges including contamination risk and genetic instability have kept fed-batch as the preferred mode for most commercial bioprocesses.